Canadian Partnership for Tomorrow’s Health

What Canadian Partnership for Tomorrow’s Health does

Canadian Partnership for Tomorrow's Health (CanPath) is a Toronto-based non-profit population health research platform founded in 2008 that operates Canada's largest population health cohort, comprising 331,359+ adult participants contributing over 1 billion data points and 178,065 biosamples across seven regional cohorts in ten provinces. The organization is jointly hosted by the Ontario Institute for Cancer Research and the University of Toronto's Dalla Lana School of Public Health, and enables academic and health researchers to investigate how genetics, environment, lifestyle, and behaviour contribute to cancer and chronic disease development through longitudinal population health data, biosample access, and linked administrative health records.

The platform's core technical offering is the CanPath Access Portal, which provides researchers with a data access request workflow and a Trusted Research Environment built in collaboration with Lifebit and AWS, enabling secure cloud-based analysis within Canadian-hosted environments that meet national data residency and privacy requirements. As of May 2026, this infrastructure has been formalized as Canada's National Federated Research Infrastructure, supporting cross-institutional federated analyses without data centralization. Additional products include the CanPath Synthetic Dataset (free for Canadian academic instructors), the biosample collection, and specialized studies including the April 2025 HEAL study (targeting 100,000 adults for dietary and physical activity data) and its CHARM extension adding fasting blood and stool biosampling.

CanPath's revenue model is dominated by public sector research grants — over $160M cumulatively since 2008, anchored by the Canadian Partnership Against Cancer (CPAC) which has invested over $80M, with additional funding from Genome Canada, CIHR, Heart and Stroke Foundation, BC Cancer Foundation, Alberta Cancer Foundation, OICR, and Genome Quebec. Secondary revenue comes from data and biosample access fees paid by researchers and institutions, with reduced fees for students and trainees; commercial pricing is not publicly disclosed. The organization has no private equity or venture capital ownership, no plans for liquidity events, and no indicated intention to alter its non-profit research infrastructure mandate.

Name

Canadian Partnership for Tomorrow’s Health

Legal name

Canadian Partnership for Tomorrow's Health

Website

https://canpath.ca

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1–10 employees

Short description

CanPath is a Toronto-based non-profit operating Canada's largest population health research cohort (331,000+ participants, 1B+ data points, 178K biosamples), enabling academic and health researchers to study cancer and chronic disease through a federated Trusted Research Environment built with Lifebit and AWS.

Ownership category

akta.pro rank

Product category

Population Health Research Platform

NAICS

Health Care and Social Assistance (62), Social Assistance (624)

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Data Linkage, Registries & Longitudinal Cohort Surveillance (HLAJANAM)

akta.pro secondary industries

Health Data, Vital Statistics & Population Health Informatics (BPAIAJAM), Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

Keywords

• Population health research
• Health data platform
• Biosample repository
• Cohort study data
• Research data access

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Research Grants and Government Funding: CanPath is entirely funded by the public sector including $42 million from the Canadian Partnership Against Cancer as lead funding, plus $57 million from regional funders including BC Cancer Foundation, Alberta Cancer Foundation, Ontario Institute for Cancer Research, and Genome Quebec. Additional investments from Heart and Stroke Foundation ($2M) for specific cardiovascular research initiatives.
2. Data Access Fees: Researchers and institutions pay reduced fees for access to CanPath data and biosamples. A reduced fee structure is available to students and trainees applying for data access.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

CanPath operates Canada's largest population health research platform, linking longitudinal health, lifestyle, environmental, and biological data from over 331,000 participants across seven regional cohorts. It provides approved researchers with access to harmonized data and physical biosamples through the CanPath Access Portal and a cloud-based Trusted Research Environment, and offers a free Synthetic Dataset for educational use. Embedded sub-studies on COVID-19 antibodies, mental health (CHARM), and pregnancy health (HEAL) extend the platform's research utility.

Product overview

CanPath operates as a platform comprising a national population health cohort (Canada's largest with 331,000+ participants) and multiple specialized research tools. The core offerings include the CanPath Cohort Platform for participant data and biosamples, the CanPath Access Portal with a Trusted Research Environment (built with Lifebit and AWS) for secure data access, and the Synthetic Dataset for educational purposes. Specialized studies under the umbrella include the HEAL and CHARM studies on dietary intake and physical activity, a COVID-19 antibody study, and seven regional cohorts (BC Generations Project, Alberta's Tomorrow Project, Healthy Future Sask, Manitoba Tomorrow Project, Ontario Health Study, CARTaGENE, Atlantic PATH). The platform supports over 100 research projects and provides access to funding opportunities.

Differentiator

Problem solved

Functional benefit

Products and services

• CanPath Cohort Platform

Quantifiable outcome

• More than 100 research projects and activities supported, with publications in high impact journals
• +1 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

16 partnerships are on record, tiered core, strategic and minor.

• LifebitcoreTechnology or Integration · 28 May 2026Lifebit, a global leader in federated data technology, partnered with CanPath to establish Canada's National Federated Research Infrastructure framework. This creates a shared approach enabling researchers to work together across institutions while keeping data secure and under local control. The infrastructure operates within Canadian-hosted cloud environments meeting national data residency and security requirements.
• Genome CanadacoreStrategic or Co-development Partner · 28 May 2026Genome Canada collaborated with CanPath and Lifebit to launch Canada's national federated research and clinical infrastructure, supporting national precision medicine initiatives and data-driven health research.
• Maelstrom ResearchstrategicStrategic or Co-development Partner · 1 January 2015Partnered to develop the Cross-Cohort Harmonization Project for Tomorrow (CHPT), creating a network that harmonizes data from 13 large cohort studies including CanPath, UK Biobank, Nurses' Health Study, and LifeLines, encompassing over 2.5 million participants.
• Heart and Stroke FoundationstrategicStrategic or Co-development Partner · 24 October 2013Invested $2 million in the Canadian Alliance for Healthy Hearts and Minds partnership ($16M total with $14M from Canadian Partnership Against Cancer), expanding CanPath research into cardiovascular diseases with MRI assessments.
• Canadian Institutes of Health Research (CIHR)strategicStrategic or Co-development Partner · 22 March 2012CIHR partnered through the Genomics and Personalized Health competition, allowing successful research teams to access and use data from CanPath. Provides research grant support including nearly $2 million to CPTP Scientific Directors.
• AWS (Amazon Web Services)coreTechnology or IntegrationAWS provides cloud infrastructure for the trusted research environment, enabling secure, cloud-based data access and analysis within Canadian-hosted environments.
• University of Toronto's Dalla Lana School of Public HealthcoreStrategic or Co-development PartnerCanPath's National Coordinating Centre is based at the Dalla Lana School of Public Health. The school hosts CanPath's operational core and provides academic oversight and research expertise. Since April 2019, the school assumed all operational and scientific responsibilities.
• Ontario Institute for Cancer Research (OICR)coreStrategic or Co-development PartnerCanPath is jointly hosted by OICR and the University of Toronto's Dalla Lana School of Public Health. OICR provides scientific leadership including the National Scientific Co-Director role.
• Genome CanadastrategicStrategic or Co-development PartnerPartnered through the Genomics and Personalized Health competition, enabling research teams to access CanPath data. Also hosts the Canadian Data Integration Centre.
• BC Generations ProjectcoreStrategic or Co-development PartnerBritish Columbia's largest-ever health study with nearly 30,000 BC participants. One of seven regional cohorts comprising CanPath's pan-Canadian partnership, hosted at BC Cancer.
• Alberta's Tomorrow ProjectcoreStrategic or Co-development PartnerAlberta's largest health research study following 55,000 men and women for 50 years. One of seven regional cohorts, collecting over a billion pieces of data and thousands of biological samples.
• Ontario Health StudycoreStrategic or Co-development PartnerOngoing research study investigating risk factors for cancer, diabetes, heart disease, asthma and Alzheimer's. Recruited over 225,000 Ontario residents and collected over 41,000 blood samples.
• CARTaGENEcoreStrategic or Co-development PartnerA public research platform of CHU Sainte-Justine consisting of biological samples and health data from 43,000 Quebec residents aged 40-69 years.
• Atlantic PATHcoreStrategic or Co-development PartnerThe Atlantic Partnership for Tomorrow's Health Study recruited over 30,000 participants from all four Atlantic Provinces, addressing the region's highest cancer rates in Canada.
• Manitoba Tomorrow ProjectminorStrategic or Co-development PartnerNew population health research study aiming to learn about causes of cancer and chronic diseases by following 10,000 Manitoba residents aged 30-74 for up to 50 years.
• Healthy Future SaskminorStrategic or Co-development PartnerCurrently in development, will create a platform for research in cancer and chronic disease prevention within Saskatchewan, adding more than 7,000 participants to the CanPath cohort.

Scale indicators7 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• deCODE Genetics: deCODE Genetics (an Amgen subsidiary) operates population-scale genomic and health research in Iceland with deep genetic, genealogical, and health outcome data. Directly comparable to CanPath in population genetics and disease causation research, though commercial rather than non-profit and based in Iceland.
• Our Future Health: Our Future Health is a UK-based population health research platform targeting up to 5 million adult participants with genomic and health data linkage. It is directly comparable to CanPath as a national-scale cohort focused on disease prevention and precision medicine, though based in a different geography.
• UK Biobank: UK Biobank is a large-scale population health cohort of ~500,000 participants with deep genomic, lifestyle, and health outcome data, widely regarded as the global gold standard for population health research platforms. It is the most directly comparable platform to CanPath in terms of cohort design, multimodal data, and researcher-access model.
• NIH All of Us Research Program: The NIH All of Us Research Program is a U.S. population health cohort targeting 1M+ participants with genomic, electronic health record, and survey data. Comparable to CanPath in mission (diverse population health research), scale ambition, and federal funding model, though materially larger and more US-centric.

Others

• Lifebit: Lifebit is a federated genomics and health data technology company that built CanPath's National Federated Research Infrastructure framework. While not a direct peer (it is a technology partner and infrastructure provider), Lifebit operates in the adjacent enabling technology layer for sovereign-by-design health data analysis.
• Maelstrom Research: Maelstrom Research is a research initiative at the Research Institute of the McGill University Health Centre specializing in cross-cohort data harmonization. Directly partnered with CanPath on the CHPT project harmonizing data across 13 international cohorts; functions as an enabling harmonization infrastructure provider.

Regional players

• FinnGen: FinnGen is a Finnish public-private partnership combining genomic data from biobanks with national health records for ~500,000 participants. Comparable to CanPath in leveraging population biobanks and linked health data for genomic discovery, though focused on Finland's unique genetic heritage.
• Genomics England: Genomics England is a UK government-owned company that delivered the 100,000 Genomes Project and now operates a genomic medicine service within the NHS. Comparable to CanPath in national-scale genomics research mission and public sector backing, though focused specifically on rare disease and cancer genomics.
• Canadian Institute for Health Information (CIHI): CIHI is an independent, not-for-profit organization that provides Canadian health data, analytics, and reporting. While operating broader administrative health data infrastructure rather than cohort research, CIHI is thematically comparable as a national health data platform and is a likely integration partner for CanPath's administrative health record linkage.
• Million Veteran Program: The U.S. Department of Veterans Affairs Million Veteran Program is one of the world's largest population health cohorts with 900,000+ veteran participants and linked genomic, survey, and health record data. Comparable to CanPath in scale, federal anchoring, and longitudinal research mission, though serving a U.S. veteran population.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/CanPath
• YouTubeyoutube.com/channel/UC6z0KnlX63WpNpivqnGW8-g
• Facebookfacebook.com/WeAreCanPath
• LinkedInlinkedin.com/company/canpath
• Instagraminstagram.com/canpath

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Canadian Partnership for Tomorrow’s Health